Benefit of Adding Trastuzumab to Second Line Chemotherapy in Breast Cancer Patients Previously Treated With Trastuzumab

Stopped A new alternative treatment caused the decrease in the rhythm of recruitment.

Conditions

• Breast Cancer

Interventions

• DRUG: Vinorelbine
• DRUG: Capecitabine
• DRUG: Trastuzumab

Sponsor

Spanish Breast Cancer Research Group

Collaborators

• [object Object]